Amicogen Inc
092040
Company Profile
Business description
Amicogen Inc is an industrial biotechnology company operating in Korea. It is engaged in the development, production, and distribution of enzymes, bio-new materials, and healthcare food. The company's product portfolio includes special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP), and protein A chromatography resins.
Contact
1259-64, Dongbu-ro
Gyeongsangnam-do
Jinseong-myeon660-852
KORT: +82 557596161
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
223
Stocks News & Analysis
stocks
Stellar growth from ASX retailer but markets still too optimistic
This Australian success story looks set to face profit margin compression from the scariest of competitors.
stocks
How to focus on the right things this reporting season
For individual investors, it is important to frame earnings season revelations in a long-term way.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,141.70 | 24.10 | 0.26% |
| CAC 40 | 7,698.52 | 44.48 | -0.57% |
| DAX 40 | 24,081.34 | 81.52 | -0.34% |
| Dow JONES (US) | 43,975.09 | 200.52 | -0.45% |
| FTSE 100 | 9,129.71 | 33.98 | 0.37% |
| HKSE | 24,929.34 | 22.53 | 0.09% |
| NASDAQ | 21,385.40 | 64.62 | -0.30% |
| Nikkei 225 | 42,969.07 | 1,148.59 | 2.75% |
| NZX 50 Index | 12,804.18 | 107.68 | -0.83% |
| S&P 500 | 6,373.45 | 16.00 | -0.25% |
| S&P/ASX 200 | 8,873.60 | 28.80 | 0.33% |
| SSE Composite Index | 3,666.33 | 18.78 | 0.51% |